![Christopher Gerry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Gerry
Conseiller Juridique Général chez
FAETH THERAPEUTICS, INC.
Fortune : 20 146 $ au 31/05/2026
Profil
Christopher W.
Gerry is currently Secretary & General Counsel at Faeth Therapeutics, Inc., a position starting in 2026.
Formerly, Mr. Gerry was Vice President & Deputy General Counsel at AVROBIO, Inc. from 2021 to 2022 and an Associate at Cooley LLP from 2013 to 2019.
Education includes undergraduate studies at Dickinson College and graduate studies at Boston University School of Law.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/06/2026 | 953 ( 0 % ) | 20 146 $ | 31/05/2026 |
Postes actifs de Christopher Gerry
| Sociétés | Poste | Début |
|---|---|---|
| FAETH THERAPEUTICS, INC. | Conseiller Juridique Général | 01/07/2022 |
Anciens postes connus de Christopher Gerry
| Sociétés | Poste | Fin |
|---|---|---|
| TECTONIC THERAPEUTIC, INC. | Corporate Officer/Principal | 01/07/2022 |
Cooley LLP
 Cooley LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/10/2019 |
Formation de Christopher Gerry
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
8
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Dickinson College
 Dickinson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cooley LLP
Cooley LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Boston University School of Law
 Boston University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVROBIO, Inc.
 AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
